Aude Ambresin

5PUBLICATIONS
12CO-AUTHORS
Optical technologyVision scienceGeneral practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 06, 2026
Intravitreal faricimab in patients with refractory diabetic macular edema: 6-month fluid analysis using artificial intelligence.

Nicolas Owlya, Mickael Barbosa, Nicolò Bartolomeo

|Jan 29, 2026
Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker Quantification.

Nicolò Bartolomeo, Konstantinos Kitsos Kalyvianakis, Yannic Pannatier Schuetz

|Dec 17, 2025
Pigment epithelial detachment as a biomarker for faricimab treatment outcomes in naïve neovascular age-related macular degeneration.

Nicolò Bartolomeo, Mickael Barbosa, Yannic Pannatier Schuetz

|Nov 19, 2025
Intravitreal faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration: short and long-term outcomes and assessment of volume dynamics using an artificial intelligence-based tool.

Mickael Barbosa, Nicolò Bartolomeo, Yannic Pannatier Schuetz

|Nov 14, 2025
Establishing Expert Consensus on a Unified Decision Framework for Retina Patient Care.

Javier Zarranz-Ventura, Aude Ambresin, Andrew Chang

Pageof 1

Frequent Collaborators

3 joint publications

Nicolò Bartolomeo

3 joint publications

Daniela Gallo Castro

2 joint publications

Yannic Pannatier-Schuetz

1 joint publications

Javier Zarranz-Ventura